#088: Immune Tolerance and MS. How the RED4MS study could change MS treatment with Dr. Andreas Lutterotti
Andreas Lutterotti explains the mode of action, the concept of the early clinical trial Red4MS, and what a success could mean for patients.
Andreas Lutterotti explains the mode of action, the concept of the early clinical trial Red4MS, and what a success could mean for patients.
Living with neuromyelitis optica spectrum disorder (NMOSD) can be challenging. But the more you understand about the condition and the
Dr. Jonathan Pansieri explains how vascular dysfunction could worsen multiple sclerosis and become a target for future treatment approaches.
Today I would like to introduce you to Dr. Sanja V. Gluscevic, a renowned neurologist who specializes in multiple sclerosis
Welcome to today’s episode. Whether you have MS, MOGAD (myelin oligodendrocyte glycoprotein antibody-associated disease), or NMOSD (neuromyelitis optica spectrum disorder),
Today I speak with Dr. Emine Rabia Koç about the important intersection between mood disorders and patient care in multiple
MS has long been known as an orphan disease in Colombia, but the increasing number of newly diagnosed patients is
Dr. Sara Samadzadeh contributes to research in the field of NMOSD and MS by creating networks between young researchers worldwide.
I show you how to make the best of your life with MS from family to career to hobbies. Thanks to science and research, a lot is possible nowadays.
Then get 11 impulses for a positive course as a gift and receive important information about the disease.
Sign up for the newsletter now and get 11 tips on how you can positively influence your progress.
Wait a moment!
Sign up for the newsletter now and get 11 tips on how you can positively influence your progress.
You are currently viewing a placeholder content from Vimeo. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More InformationYou are currently viewing a placeholder content from YouTube. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More InformationYou need to load content from reCAPTCHA to submit the form. Please note that doing so will share data with third-party providers.
More InformationYou are currently viewing a placeholder content from Facebook. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More Information
